AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 34 filers reported holding AC IMMUNE SA in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,420 | -57.6% | 1,200 | -56.1% | 0.00% | – |
| Q2 2023 | $8,073 | +34.6% | 2,732 | 0.0% | 0.00% | – |
| Q1 2023 | $6,000 | +99900.0% | 2,732 | 0.0% | 0.00% | – |
| Q4 2022 | $6 | -100.0% | 2,732 | -48.2% | 0.00% | – |
| Q3 2022 | $17,000 | +30.8% | 5,271 | +50.1% | 0.00% | – |
| Q2 2022 | $13,000 | -65.8% | 3,512 | -62.8% | 0.00% | – |
| Q1 2022 | $38,000 | +8.6% | 9,430 | +34.1% | 0.00% | – |
| Q4 2021 | $35,000 | -67.9% | 7,032 | -56.4% | 0.00% | – |
| Q3 2021 | $109,000 | +303.7% | 16,131 | +368.8% | 0.00% | – |
| Q2 2021 | $27,000 | – | 3,441 | +10327.3% | 0.00% | – |
| Q1 2021 | $0 | – | 33 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 33 | -99.3% | 0.00% | – |
| Q4 2019 | $43,000 | -56.6% | 5,059 | -72.1% | 0.00% | – |
| Q2 2019 | $99,000 | +30.3% | 18,162 | +20.7% | 0.00% | – |
| Q1 2019 | $76,000 | -46.5% | 15,049 | -15.5% | 0.00% | – |
| Q3 2018 | $142,000 | +1083.3% | 17,803 | +1467.2% | 0.00% | – |
| Q1 2017 | $12,000 | – | 1,136 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Duquesne Family Office | 1,500,000 | $24,705,000 | 2.18% |
| Monashee Investment Management LLC | 275,000 | $4,529,000 | 1.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 79,800 | $1,314,000 | 0.21% |
| Hillhouse Capital Management | 550,000 | $9,059,000 | 0.18% |
| Temasek Holdings (Private) Ltd | 1,337,500 | $22,029,000 | 0.18% |
| PointState Capital LP | 425,000 | $7,000,000 | 0.07% |
| Artal Group S.A. | 150,000 | $2,471,000 | 0.05% |
| HIGHLAND CAPITAL MANAGEMENT LP | 87,900 | $1,448,000 | 0.04% |
| Schonfeld Strategic Advisors LLC | 14,779 | $243,000 | 0.04% |
| Point72 Hong Kong Ltd | 4,000 | $66,000 | 0.04% |